Sunday - December 22, 2024

Crystalline and Amorphous Forms of a Compound for the Targeted Degradation of Estrogen Receptor

2024-12-10

ALEXANDRIA, Virginia, Dec. 10 -- ARVINAS OPERATIONS, INC., New Haven, Connecticut has been assigned a patent (No. US 12162859 B2, initially filed Sept. 13, 2021) developed by four inventors Katharine Victoria Boulton, Edinburgh, United Kingdom; Chungpin Herman Chen, Madison, Connecticut; Royal J. Haskell, III, Durham, Connecticut; and Hayley Reece, Dalkeith, United Kingdom, for "Crystalline and amorphous forms of a compound for the targeted degradation of estrogen receptor." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Crystalline and Amorphous Forms of a Compound for the Targeted Degradation of Estrogen Receptor

Information Request Form

Copyright Targeted News Service 2024